Jadegoud Yaligar1, Rengaraj Anantharaj1, Le Thi Thu Giang1, Sanjay Kumar Verma1, Venkatesh Gopalan1, Bhanu Prakash K N1, Karthik Mallilankaraman2, and S. Sendhil Velan1
1Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, Singapore, Singapore, 2Department of Physiology, National University of Singapore, Singapore, Singapore
Synopsis
High-GI diet has been
linked with insulin resistance, type 2 diabetes and cardiovascular risk factors.
Brown fat activity positively correlates with increased energy expenditure
during β3-agonist/cold induced BAT activation, suggesting regulatory link
between BAT and energy metabolism. In this study we evaluated long term metabolic
effects of high and low-GI diets on brown adipose tissue metabolism and ectopic
fat accumulation in liver and abdomen by MRI and MRS. Low-GI diet fed animals were responsive to
prolonged BAT activation for metabolizing the fat. Weight and volumes of iBAT
increased with β3-agonist treatment, implying potential remodeling of WAT into
Beige.
Purpose
Evaluating the metabolic effects of brown adipose tissue in response to high
glycaemic diet and systemic effects on whole body fat metabolism.Introduction
Worldwide dietary patterns have turned toward to increased intake of
refined carbohydrate and higher glycaemic index (GI) diets. High-GI diet has
been linked with insulin resistance, type2 diabetes and cardiovascular diseases
independent of bodyweight1-3 and low GI diets have been associated with
improved insulin sensitivity. Brown adipose tissue (BAT) activity positively
correlates with increment of energy expenditure during β3-agonist or cold
induced BAT activation, suggesting a regulatory link between BAT and energy
metabolism4. In this study we evaluated the long term metabolic effects of high and
low GI diets on BAT metabolism and ectopic fat accumulation in liver and
abdomen.Methods
Eight weeks old,Wister rats were randomized into two cohorts; cohort-1(n=10)
and cohort-2 (n=10), were fed high and low GI diet from week 8 to 19. After 19th
week, each cohort was subdivided into Group 1 and 2, which were treated with
saline and CL-316243 for 14 days respectively. Longitudinal MRS and MRI
measurements were performed at 8, 12, 16, 19, 20 (day 7) and 21 (day 14) weeks
of age with 7T MRI/MRS scanner using 72 mm volume transmit and 2x2 phased array
coils. Dixon
imaging was performed in iBAT and in abdomen. Imaging parameters were: FOV;54x54mm2,
matrix size;256×256, resolution;211μmx211μm, ST; 1mm, TR;8ms, FA;8°,
out-of-phase(1.0ms) and in-phase(2.5ms) echo times. Localized MRS was performed
with PRESS sequence in liver with TR/TE;4s/TE13ms, NA;64, voxel volume;64 mm3.
Fat content from in vivo spectra were quantified using LC Model software5.Results and Discussion
Figure 1 shows body weight curves of rats fed with
high & low GI diets. Body weight of high GI group rats was significantly
higher starting from 11
th week compared to low GI group. Figure-2A,B
shows the longitudinal fat fraction (FF) images and Figure 2C shows the
quantitative FF from iBAT region of high and low GI diet groups. In high
GI group the FF significantly increased from 61.0±2.3% (week 8) to 70.6±1.3% (week 21)
and in low GI group the FF increased from 60.9±1.6% to 67.18±3.8%. At day 7 of β3-agonist
treatment, the FF reduced in both high and low GI groups of rats. Reduction in
FF at day 7 in β3-agonist treated high and low GI groups was 21.1 and 23.3%. At
day 14, the FF in high GI group did not decrease further where as in low GI the
FF reduced to 35.9 %, indicating that the low GI diet was responsive to
prolonged BAT activation for metabolizing the fat. Reduction of fat content
after activation implies the lipolysis of lipids into free fatty acids utilized
in β oxidation for thermogenesis. Fat pad measurements (Figures 3A,B) were
performed to verify the imaging results. With the long term of feeding of GI
(high and low) diets, the weight of iBAT kept reducing significantly (P<0.05) at 12, 16
and 21 weeks of age whereas after treating the animals with β3-agonist for 14
days, the weight and volume of iBAT got increased (P<0.05). Weight of iWAT decreased during the β3 agonist treatment
which implies potential remodeling of WAT into beige fat. To understanding the
response of abdominal fat with iBAT activation, we evaluated the visceral
adipose tissue (VAT) and subcutaneous adipose tissue (SAT) volumes in both high
and low GI groups. Figure-4A shows the abdominal fat segmentation images from
high and low GI diet groups. Abdominal VAT (Figure-4B) and SAT (Figure-4C) volumes
were significantly higher in high GI group compared to low GI group until 19
weeks. After day 7 and 14 of β3-agonist treatment, VAT volume decreased
significantly both in high and low GI groups. Decrease in VAT (gonadal,
mesenteric, retroperitoneal) was confirmed by fat pad measurements (Figure-4D).
The
liver fat (Figure-5A,B) increased progressively in high GI group and was
significantly higher than low GI group. Excessive accumulation of lipids in liver
is due to the De novo lipogenesis of carbohydrates from high GI diet gets
converted into fatty acids which are then esterified to triacylglycerides.
Conclusions
High GI diet fed group showed significant increase in body weight
compared to low GI diet group. FF in iBAT of high and low GI diet groups
significantly increased with diet intervention until 19 weeks and reduced with
BAT activation. Low GI diet fed animals were responsive to prolonged
BAT activation for metabolizing the fat. Weight and volumes of the iBAT
increased with β3-agonist treatment, implying potential remodeling of WAT into
Beige fat. Abdominal VAT and SAT volumes were significantly higher in high GI
group compared to low GI group. Visceral fat volumes reduced significantly in both
groups in response to the β3 agonist intervention.Acknowledgements
No acknowledgement found.References
- Christian K. Roberts, and Simin Liu, J Diabetes Sci Technol. 2009, 3, 697–704.
- Henry, C.J.K., & Ranawana, V. Nature, 482(7386): 471.
(DOI:10.1038/482471a)
- Walter Willett, JoAnn Manson, and Simin Liu, Am J Clin Nutr , 2002,76,
274S-280S
- Villarroya L. et al, An
endocrine role for brown adipose tissue. Am J Physiol Endocrinol Metab.
2013;305:E567-E572
- Provencher SW. Automatic
quantitation of localized in vivo 1H spectra with LCModel.NMR Biomed.
2001;14:260-264.